Adage Capital Partners Gp, L.L.C. Mereo Biopharma Group PLC Transaction History
Adage Capital Partners Gp, L.L.C.
- $51 Billion
- Q1 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Mereo Biopharma Group PLC stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 9,328,739 shares of MREO stock, worth $33.6 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
9,328,739
Previous 2,650,000
252.03%
Holding current value
$33.6 Million
Previous $6.12 Million
402.92%
% of portfolio
0.06%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding MREO
# of Institutions
88Shares Held
85.6MCall Options Held
182KPut Options Held
249K-
Rubric Capital Management LP New York, NY13.6MShares$48.8 Million1.52% of portfolio
-
Mangrove Partners New York, NY8.75MShares$31.5 Million3.09% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD8.14MShares$29.3 Million0.7% of portfolio
-
683 Capital Management, LLC New York, NY5.75MShares$20.7 Million1.62% of portfolio
-
Janus Henderson Group PLC London, X05.12MShares$18.4 Million0.01% of portfolio
About Mereo Biopharma Group plc
- Ticker MREO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,986,000
- Market Cap $450M
- Description
- Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...